Phenotypic approach to personalization of pharmacotherapy in patients with congenetive heart failure with low left ventricular ejection fraction

Objective is to present a review of the literature data concerning the personalization of pharmacotherapy in patients with chronic heart failure with low left ventricular ejection fraction. The article discusses modern approaches to phenotyping patients with chronic heart failure with a low left ventricular ejection fraction (HFrEF). Various criteria of phenotyping are considered, both technologically complex and having the prospect of implementation into real practice in the future, and currently being implemented. For the current period, the most acceptable approach from a practical point of view remains the phenotyping of patients with HFrEF, based on clinical, hemodynamic parameters, which allows prioritizing the appointment of medicines. The article discusses the choice of optimal classes of drugs that affect the prognosis of patients with HFrEF, based on taking into account such markers as blood pressure, heart rate, presence of atrial fibrillation, presence and degree of renal dysfunction, electrolyte balance, a combination of these parameters. A phenotypic approach to the treatment of patients with HFrEF will help to ensure the personalization of pharmacotherapy for heart failure with maximum benefit for a particular patient.